Journal of Vaccine Research 2024, Vol.14, No.4, 157-169 http://medscipublisher.com/index.php/jvr 169 Xu W., and Li J.H., 2024, Peptide-based vaccines for oral cancer: mechanisms of action and clinical outcomes, International Journal of Clinical Case Reports, 14(3): 132-143. https://doi.org/10.5376/ijccr.2024.14.0015 Yam K.K., Gupta J., Winter K., Allen E., Brewer A., Beaulieu É., Mallett C.P., Burt D.S., and Ward B.J., 2015, AS03-adjuvanted, very-low-dose influenza vaccines induce distinctive immune responses compared to unadjuvanted high-dose vaccines in BALB/c mice, Frontiers in Immunology, 6: 207. https://doi.org/10.3389/fimmu.2015.00207 PMid:25972874 PMCid:PMC4413846 Zost S.J., Wu N.C., Hensley S.E., and Wilson I.A., 2019, Immunodominance and antigenic variation of influenza virus hemagglutinin: implications for design of universal vaccine immunogens, The Journal of Infectious Diseases, 219(Supplement_1): S38-S45. https://doi.org/10.1093/infdis/jiy696 PMid:30535315 PMCid:PMC6452323
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==